Risk Communications Panel To Discuss Public Confusion, “Message Fatigue”
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA advisory committee will again consider whether consumers have an inaccurate understanding of drug risks or are so overwhelmed by messages about them that they discount the warnings.